ACA vs PRLB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

ACA

54.3
AI Score
VS
ACA Wins

PRLB

39.9
AI Score

Investment Advisor Scores

ACA

54score
Recommendation
HOLD

PRLB

40score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric ACA PRLB Winner
Forward P/E 35.8423 32.2581 PRLB
PEG Ratio 2.2415 0.8585 PRLB
Revenue Growth 1.7% 10.6% PRLB
Earnings Growth 448.6% 105.6% ACA
Tradestie Score 54.3/100 39.9/100 ACA
Profit Margin 16.8% 5.4% ACA
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL ACA

Relative Price Performance (Last 90 Days)

ACA 1M: -0.1% · 3M: +21.6% PRLB 1M: +1.3% · 3M: +14.1%

Current Technical Phase

ACA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.3% over 20 days), RSI 55

RSI (14): 54.6 · Price: $144.90

PRLB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 43.2 · Price: $79.61

Fundamentals Snapshot

Metric ACA PRLB
Market Cap
Forward P/E 28.3 33.0
Trailing P/E 32.5 67.8
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.2% 0.5%
Operating Margin 0.1% 0.1%
EPS 4.47 1.21
Dividend Yield 0.00%

Frequently Asked Questions

Based on our detailed analysis, ACA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.